• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Catalog Number 1125225-23
Device Problems Failure to Advance (2524); Device Dislodged or Dislocated (2923)
Patient Problems Vessel Or Plaque, Device Embedded In (1204); Occlusion (1984)
Event Date 07/18/2018
Event Type  Injury  
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.The device was received.Investigation is not yet complete.A follow up report will be submitted with all relevant information.
 
Event Description
It was reported that the procedure was to treat lesions in the left anterior descending (lad), diagonal and circumflex coronary arteries with 85% stenosis and heavy calcification.A 2.25x23 mm xience alpine stent delivery system (sds) was advanced but failed to cross the lesion in the 1st diagonal due to the patient anatomy.The 2.25x23 mm sds was withdrawn with no resistance when the stent dislodged in the proximal lad.Balloon angioplasty was performed to crush the stent against the vessel wall in the proximal lad.Post balloon angioplasty, the diagonal artery became completely occluded.No plaque shift was reported.An additional two xience alpine stents were implanted in the proximal and mid lad overlapping the crushed 2.25x23 mm stent.No treatment was performed for the occluded diagonal artery.There was no reported clinically significant delay in the procedure and no reported patient symptoms as a result of the occluded diagonal artery.No additional information was provided.
 
Manufacturer Narrative
(b)(4).The device was returned for analysis.The reported stent dislodgement was confirmed.The reported failure to advance the device was unable to be replicated in a testing environment as it was based on operational circumstances.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history did not indicate a lot specific quality issue.The investigation determined the reported difficulties and treatment appear to be related to circumstances of the procedure as it is likely the device interacted with the difficult anatomy during advancement causing the reported failure to advance.Although the stent dislodged during the withdrawal of the device it is likely the interaction of the device with the difficult anatomy during the attempted advancement caused reported stent dislodgement and subsequent patient effects of device embedded, occlusion, and additional therapy/non-surgical treatment.The reported patient effect of occlusion is listed in the xience alpine everolimus eluting coronary stent systems instructions for use as a known patient effect of coronary stenting procedures.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer (Section G)
CLONMEL, IRELAND REG# 9616693
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key7777191
MDR Text Key116907060
Report Number2024168-2018-06210
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Remedial Action Other
Type of Report Initial,Followup
Report Date 08/17/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/13/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/15/2021
Device Catalogue Number1125225-23
Device Lot Number8020641
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer07/25/2018
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/15/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/01/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-